Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. (Q45117946)
Jump to navigation
Jump to search
scientific article published in September 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. |
scientific article published in September 2004 |
Statements
Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo (English)
Carsten Rudolph
Ulrike Schillinger
Aurora Ortiz
Kerstin Tabatt
Rainer H Müller
Joseph Rosenecker
1 September 2004
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference